Human papilloma virus molecular profile and mechanisms of cancerogenesis: A review

European Journal of Gynaecological Oncology

Volumn 30, Issue 2, 2009, Pages 128-132

  Deligeoroglou, E ^a   Christopoulos, P ^a,b   Aravantinos, L ^a   Papadias, K ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Cervical cancer; Epidemiology; Genes; HP; Infection; Molecular biology

Indexed keywords

PROTEIN E6; PROTEIN E7;

CIGARETTE SMOKING; EPITHELIUM CELL; FOOD INTAKE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; NONHUMAN; ORAL CONTRACEPTION; REVIEW; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS;

FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 65349135878     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Kahn J.A., Rosenthal S.L., Succop P.A., Ho G.Y., Burk R.D.: "The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women". J. Pediatr., 2002, 141, 718.
2. Revzina N.V., Diclemente R.J.: "Prevalence and incidence of human papillomavirus infection in women in the USA: a systematic review". Int. J. Std. AIDS, 2005, 16, 528.
3. Winer R.L., Lee S.K., Hughes J.P., Adam D.E., Kiviat N.B., Koutsky L.A.: "Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students". Am. J. Epidemiol., 2003, 157, 218.
4. Eaton L., Kalichman S., Cain D., Cherry C., Pope H., Fuhrel A., Kaufman M.: "Perceived prevalence and risks for human papillomavirus (HPV) infection among women who have sex with women". J. Womens Health (Larchmt), 2008, 17, 75.
5. Reich O., Pickel H., Regauer S.: "Why do human papillomavirus infections induce sharply demarcated lesions of the cervix?". J. Low Genit. Tract. Dis., 2008, 12, 8.
6. Moreno V., Munoz N., Bosch F.X., De San Jose S., Gonzalez L.C., Tafur L., Gili M., Izazugasa I., Navarro L., Vergara A.: "Risk factors for progression of CIN Grade III to invasive CC". Cancer Epidim. Biomarkers Preview, 1995, 4, 459.
7. Clifford G.M., Smith J.S., Plummer M., Muñoz N., Franceschi S.: "Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis". Br. J. Cancer, 2003, 88, 63.
8. Schiffman M., Castle P.E., Jeronimo J., Rodriguez A.C., Wacholder S.: "Human papillomavirus and cervical cancer". Lancet, 2007, 370, 890.
9. Ishida W.S., Singto Y., Kanjanavirojkul N., Chatchawan U., Yuenyao P., Settheetham D., Ishida T.: "Co-risk factors for HPV infection in Northeastern Thai women with cervical carcinoma". Asian Pac. J. Cancer Prev., 2004, 5, 383.
10. Bibbo M., Krebler C.M., Wied G.L.: "Prevelence and incidence rates of Cervical atypia: A computerized file analysis on 148735 patients". J. Repr. Med., 1971, 6, 184.
11. Paavonen J.: "Human papillomavirus infection and the development of cervical cancer and related genital neoplasias". Int. J. Infect. Dis., 2007, 11 (suppl. 2), S3.
12. Parkin D.M., Bray F., Ferlay J., Pisani P.: "Estimating the world Cancer burden: Globocan 2000". Int. J. Cancer, 2001, 94, 153.
13. Arbyn M., Raifu A.O., Autier P., Ferlay J.: "Burden of cervical cancer in Europe: estimates for 2004". Ann. Oncol., 2007, 18, 1708.
14. Lonky N.M.: "Reducing death from cervical cancer examining the prevention paradigms". Obstet. Gynecol. Clin. North Am., 2002, 29, 599.
15. Stoler M.H.: "HPV & CC a model for carcinogenesis". Int. J. Gynaecol. Path., 2000, 19, 16.
16. Koss L.G., Durfee G.R.: "Unusual patterns of squamus epithelia of Uterine Cervix: Cytologic and pathologic study of koilocytotic atypia". Ann. N.Y. Acad. SC., 1956, 63, 1245.
17. Beckman A.M., Myerson D., Daling J.R., Kriviat W.B., Fenoglio C.M., McDougall J.K.: "Detection & localization of HPV DNA in human genital condylomas by in situ hybridization with biotinylated probes". J. Med. Virol., 1985, 16, 265.
18. Schneider A., Olfersdorf T., Schneider V., Gissmann L.: "Distribution pattern of HPV 16 genome in cervical neoplasia by molecular in situ hybridization of tissue sections". Int. J. Cancer, 1987, 39, 717.
19. Crum C.P., Mitao M., Levine R.U., Silverstein S.: "Cervical pappiloma virus segregate within morphologically dinstinct precancerous lesions". J. Virology, 1985, 54, 675.
20. González Martín A.: "Molecular biology of cervical cancer". Clin. Transl. Oncol., 2007, 9, 347.
21. Rosty C., Sheffer M., Tsafrir D., Stransky N., Tsafrir I., Peter M. et al.: "Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma". Oncogene, 2005, 24, 7094.
22. Stanley M.A.: "Human papillomavirus and cervical carcinogenesis". Best Pract. Res. Clin. Obstet. Gynaecol., 2001, 15, 663.
23. Reddout N., Christensen T., Bunnell A., Jensen D., Johnson D., O'Malley S. et al.: "High-risk HPV types 18 and 16 are potent modulators of oral squamous cell carcinoma phenotypes in vitro". Infect. Agent. Cancer, 2007, 2, 21.
24. Bauer A.M., Ting Y., Greer C.E., Chambers J.C., Tachiro C.J., Chimera J., Reingold A., Manos M.M.: "Genital HPV infections in female University students as determined by PCR based method". JAMA, 1991, 265, 472.
25. Creatsas G.: "Gynaecology", "Disease of the Uterine Cervix". In: "Current Obstetrics and Gynecology". G. Creatsas, Athens, Paschalides Pub., 1998, 232.
26. Castellsague X., Bosch F.X., Munoz N.: "Enviromental co-factors in HPV carcinogenesis". Virus Res., 2002, 89, 191.
27. Steben M., Duarte-Franco E.: "Human papillomavirus infection: epidemiology and pathophysiology". Gynecol. Oncol., 2007, 107 (suppl. 2), S2.
28. Moreno V., Bosch F.X., Munoz N., Meijer C.J., Shah K.V., Walboomers J.M. et al.: "Effect of OC in risk of CC in women with HPV infection. The IARC multicentric case-control study". Lancet, 2002, 359,1085.
29. International Agency for Research on Cancer. "Hormonal contraception and postmenopausal hormonal therapy" Vol. 72. In: "IARC monographs on the evaluation of carcinogenic risk to humans". IARC. Lyon 1999.
30. Kim C.J., Um S.J., Kim T.Y., Kim E.J., Park T.C., Kim S.J. et al.: "Regulation of cell growth and HPV genes by exogenous estrogen in cervical cancer cells". Int. J. Gynecol. Cancer, 2000, 10, 157.
31. Park J.S., Rhyu J.W., Kim C.J., Kim H.S., Lee S.Y., Kwon Y.I. et al.: "Neoplastic change of squamo-columnar junction in uterine cervix and vaginal epithelium by exogenous estrogen in hpv-18 URR E6/E7 transgenic mice". Gynecol. Oncol., 2003, 89, 360.
32. Gunnell A.S., Tran T.N., Torrång A., Dickman P.W., Sparén P., Palmgren J. et al.: "Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development". Cancer Epidemiol. Biomarkers Prev., 2006, 15, 2141.
33. Wu M.T., Lee L.H., Ho C.K., Liu C.L., Wu T.N., Wu S.C. et al.: "Lifetime exposure to environmental tobacco smoke and cervical intraepithelial neoplasms among nonsmoking Taiwanese women". Arch. Environ. Health, 2003, 58, 353.
34. Prokopczyk B., Cox J.E., Hoffmann D., Waggoner S.E.: "Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers". J. Natl. Cancer Inst., 1997, 89, 868.
35. Poppe W.A., Ide P.S., Drijkoningen M.P., Lauweryns J.M., Van Assche F.A.: "Tobacco smoking impairs the local immunoserveillance in the uterine cervix. An immunohistochemical study". Gynaecol. Obstet. Invest., 1995, 39, 34.
36. Szareski A., Jarvis M.J., Sasieni P., Anderson M., Edwards R., Steele S.J. et al.: "Effect of smoking cessation on cervical lesion size". Lancet, 1996, 347, 941.
37. Anttila T., Saikku P., Koskela P., Bloigu A., Dillner J., Ikaheimo I. et al.: "Serotypes of Chlamydia Trachomatis and risk for development of cervical squamus cell carcinoma". J. Am. Med. Assoc., 2001, 285, 47.
38. La Ruche G., You B., Mensah-Ado I., Bergeron C, Montcho C., Ramon R. et al.: "HPV and HIV infections: relation with cervical dysplasia - neoplasia in African women". Int. J. Cancer, 1998, 76, 480.
39. Working group on Diet and Cancer: "Working group on diet and cancer of the committee on medical aspects of food and nutrition policy, nutritional aspects of the development of cancer". Department of Health, UK. Rep. Health Soc. Subj., London, 1998.
40. Goodman M.T., McDuffie K., Hernandez B., Wilkens L.R., Bertram C.C., Killen J. et al.: "Association of methylenetetrahydrofollate reductase polymorphism C677T and dietary follate with the risk of cervical dysplasia". Cancer Epidim. Biomark. Prev., 2001, 10, 1275.
41. Castellsague X., Bosch F.X., Munoz N., Meijer C.J., Shah K.V., de Sanjose S. et al.: "Male circumcision, penile HPV infection and cervical cancer in female partners". New Engl. J. Med., 2002, 346, 1105.
42. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V.: "The causal relation between HPV and cervical cancer". J. Clin. Path., 2002, 55, 244.
43. Castle P.E., Hillier S.L., Rabe L.K., Hildesheim A., Herrero R., Bratti M.C. et al.: "An association of cervical inflammation with high grade cervical neoplasia in women infected with oncogenic HPV". Cancer Epid. Biomark. Prev., 2001, 10, 1021.